We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+8.89%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.6B
AUM Growth
-$3.14B
Cap. Flow
-$4.13B
Cap. Flow %
-28.38%
Top 10 Hldgs %
20.74%
Holding
1,655
New
313
Increased
216
Reduced
349
Closed
770

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$214M
2
MDT icon
Medtronic
MDT
+$123M
3
CHTR icon
Charter Communications
CHTR
+$97.9M
4
MRK icon
Merck
MRK
+$94M
5
ZTS icon
Zoetis
ZTS
+$91.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$253M
2
BIDU icon
Baidu
BIDU
+$120M
3
STZ icon
Constellation Brands
STZ
+$110M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$104M
5
ABT icon
Abbott
ABT
+$98.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.1%
2 Technology 16.39%
3 Industrials 11.22%
4 Consumer Discretionary 9.86%
5 Financials 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DINO icon
801
HF Sinclair
DINO
$14.5B
$280K ﹤0.01%
4,000
-5,100
-56% -$360K
EL icon
802
Estee Lauder
EL
$32B
$280K ﹤0.01%
1,928
-209,374
-99% -$29.1M
GGG icon
803
Graco
GGG
$13.5B
$279K ﹤0.01%
+6,035
New +$281K
PAGP icon
804
Plains GP Holdings
PAGP
$4.9B
$279K ﹤0.01%
+11,382
New +$282K
FFBC icon
805
First Financial Bancorp
FFBC
$3.53B
$275K ﹤0.01%
+9,261
New +$287K
BNFT
806
DELISTED
Benefitfocus, Inc.
BNFT
$274K ﹤0.01%
6,778
-263,382
-97% -$10.1M
VCEL icon
807
Vericel Corp
VCEL
$2.31B
$268K ﹤0.01%
18,898
-1,296,652
-99% -$15.2M
VTAK icon
808
Catheter Precision
VTAK
$1.01M
– –
0
– –
MWA icon
809
Mueller Water Products
MWA
$4.16B
$259K ﹤0.01%
+22,540
New +$267K
WING icon
810
Wingstop
WING
$3.18B
$258K ﹤0.01%
+3,777
New +$227K
OTLK icon
811
Outlook Therapeutics
OTLK
$191M
$257K ﹤0.01%
1,636
– –
ORBK
812
DELISTED
Orbotech Ltd
ORBK
$257K ﹤0.01%
+4,331
New +$271K
BIO icon
813
Bio-Rad Laboratories Class A
BIO
$9.42B
$255K ﹤0.01%
812
-2,081
-72% -$646K
JCI icon
814
Johnson Controls International
JCI
$92.2B
$252K ﹤0.01%
+7,200
New +$265K
AM icon
815
Antero Midstream
AM
$10.1B
$248K ﹤0.01%
+14,700
New +$269K
PCTY icon
816
Paylocity
PCTY
$7.98B
$246K ﹤0.01%
3,069
-331,599
-99% -$23.5M
B
817
DELISTED
Barnes Group Inc.
B
$246K ﹤0.01%
+3,464
New +$229K
RARE icon
818
Ultragenyx Pharmaceutical
RARE
$2.55B
$245K ﹤0.01%
+3,212
New +$261K
PRK icon
819
Park National Corp
PRK
$3.67B
$244K ﹤0.01%
+2,313
New +$254K
RF icon
820
Regions Financial
RF
$26.8B
$244K ﹤0.01%
+13,300
New +$250K
GSM icon
821
FerroAtlántica
GSM
$839M
$243K ﹤0.01%
29,775
-83,987
-74% -$672K
AVY icon
822
Avery Dennison
AVY
$13.4B
$240K ﹤0.01%
+2,215
New +$238K
TLND
823
DELISTED
Talend S.A. American Depositary Shares
TLND
$240K ﹤0.01%
3,433
-259,032
-99% -$16.3M
PRAH
824
DELISTED
PRA Health Sciences, Inc.
PRAH
$236K ﹤0.01%
+2,148
New +$224K
MINI
825
DELISTED
Mobile Mini Inc
MINI
$233K ﹤0.01%
+5,311
New +$236K
31 32
33
34 35

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q3 2018 Portfolio in Review

As of Q3 2018, Marshall Wace North America held 1,655 positions worth $14.6B, down 18% from $17.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Marshall Wace North America withdrew a net $4.13B in Q3 2018, closing 770 positions and reducing 349 holdings. Its most notable exit was Baidu, an estimated $120M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Marshall Wace North America opened a new position in Medtronic worth $130M.

  • Marshall Wace North America's largest Q3 2018 buy was Medtronic: 1,325,878 shares worth $130M.
  • Marshall Wace North America added most to Alphabet (Google) Class A in Q3 2018, an estimated $214M increase.
  • Marshall Wace North America's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $253M.
  • Marshall Wace North America fully exited Baidu in Q3 2018, selling an estimated $120M.
  • Marshall Wace North America's ten largest holdings make up 21% of its $14.6B portfolio in Q3 2018.
  • Marshall Wace North America opened 313 new positions and closed 770 in Q3 2018.
  • Marshall Wace North America's portfolio value fell 18% quarter-over-quarter to $14.6B.

Based on Marshall Wace North America's 13F filing for Q3 2018, filed 14 Nov 2018.